Get started
RocketTickers

Aquestive Therapeutics Reports Positive Topline Data from Phase

Long
Aquestive Therapeutics, Inc. (NASDAQ:AQST)  
RocketTickers  
NASDAQ:AQST   Aquestive Therapeutics, Inc.
Beyond Technical Analysis
0
0
beyondta
AQST: Aquestive Therapeutics, Inc.
2021-10-25 08:31:00
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.